Management of insomnia in primary care [Correction]
- First published 10 August 2021
- Aust Prescr 2021;44:177
- 1 October 2021
- DOI: 10.18773/austprescr.2021.043
The article on management of insomnia in primary care (Aust Prescr 2021;44:124-8) has been corrected. View corrected article.
In the drug management paragraph on melatonin, the treatment duration should have been over a ‘three-week period’ rather than a 13-week period: “Melatonin (2 mg extended-release formulation) is effective in treating insomnia in adults over the age of 55 over a three-week period.”